Wednesday, July 19, 2017 12:10 PM EDT
BriaCell Therapeutics Corp. continues to enroll patients in its Phase 1/2a clinical trial of BriaVax for the treatment of advanced breast cancer.
In this article: BCTXW
Latest Comments
Vitality Biopharma Taking Cannabinoid Research To The Next Level
I can't control what others do. It certainly isn't me making random phone calls to people.
Vitality Biopharma Taking Cannabinoid Research To The Next Level
Yikes
Why After A Massive Run, CoLucid Shares Still Look Attractive
What does everyone think of this idea?